Full Press Release Details
FDA Approves EYLEA® (aflibercept) Injection for Diabetic Retinopathy.
REGN
FDA Approves EYLEA® (aflibercept) Injection for Diabetic Retinopathy
Key Takeaway: FDA Approves EYLEA® (aflibercept) Injection for Diabetic Retinopathy